Insider track record Other Across 22 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Explore the complete record of transactions filed by Sally Jackson. Insider active across 1 company, notably GSK plc. Cumulatively, 84 reports have been recorded. Activity tracked since 27 July 2023. The latest transaction was filed on 9 December 2025 (Purchase). Regulator: RNS (LSE). All data is free.
Declarations 84 total
● SVP, Global Communications and CEO Office · Executives · 9 Dec 2025 · GSK plc 14 shares @ £18.0779 0.0% of flow GB00BN7SWP63⌘ RNS:58b71e9c-e0b4-4fdd-8b21-5f1119d38ddd-3 Ideal exit: 5 Sept 2026 (T+270) ● SVP, Global Communications & CEO Office · Executives · 5 Dec 2025 · GSK plc 6,000 shares @ £18.287 2.0% of flow GB00BN7SWP63⌘ RNS:b8859fbc-c269-4732-8ab1-9eb1cf1708f0 ● SVP, Global Communications and CEO Office · Executives · 11 Nov 2025 · GSK plc 14 shares @ £18.1421 0.0% of flow GB00BN7SWP63⌘ RNS:802a4789-60c0-4a7f-a34b-b750f1d9f048-3 Ideal exit: 8 Aug 2026 (T+270) ● SVP, Global Communications and CEO Office · Executives · 10 Oct 2025 · GSK plc 524 shares @ £16.40 0.2% of flow GB00BN7SWP63⌘ RNS:5862277-4 ● SVP, Global Communications and CEO Office · Executives · 9 Oct 2025 · GSK plc 1 shares @ £16.40 0.0% of flow GB00BN7SWP63⌘ RNS:5859068-10 Ideal exit: 6 Jul 2026 (T+270) ● SVP, Global Communications and CEO Office · Executives · 9 Oct 2025 · GSK plc 0
GB00BN7SWP63⌘ RNS:5859068-16 Ideal exit: 6 Jul 2026 (T+270) ● SVP, Global Communications and CEO Office · Executives · 9 Oct 2025 · GSK plc 19 shares @ £16.3921 0.0% of flow GB00BN7SWP63⌘ RNS:5859068-3 Ideal exit: 6 Jul 2026 (T+270) ● SVP, Global Communications and CEO Office · Executives · 9 Oct 2025 · GSK plc 14 shares @ £16.4086 0.0% of flow GB00BN7SWP63⌘ RNS:5857218-3 Ideal exit: 6 Jul 2026 (T+270) ● SVP, Global Communications and CEO Office · Executives · 9 Sept 2025 · GSK plc 18 shares @ £14.8572 0.0% of flow GB00BN7SWP63⌘ RNS:5815851-3 Ideal exit: 6 Jun 2026 (T+270) ● SVP, Global Communications and CEO Office · Executives · 11 Aug 2025 · GSK plc 18 shares @ £14.0844 0.0% of flow GB00BN7SWP63⌘ RNS:5777526-3 Ideal exit: 8 May 2026 (T+270) ● SVP, Global Communications and CEO Office · Executives · 11 Jul 2025 · GSK plc 0
GB00BN7SWP63⌘ RNS:5739159-7 Ideal exit: 7 Apr 2026 (T+270) ● SVP, Global Communications and CEO Office · Executives · 11 Jul 2025 · GSK plc 1 shares @ £14.49 0.0% of flow GB00BN7SWP63⌘ RNS:5739159-0 Ideal exit: 7 Apr 2026 (T+270) ● SVP, Global Communications and CEO Office · Executives · 10 Jul 2025 · GSK plc 21 shares @ £14.4448 0.0% of flow GB00BN7SWP63⌘ RNS:5737340-12 Ideal exit: 6 Apr 2026 (T+270) ● SVP, Global Communications and CEO Office · Executives · 10 Jul 2025 · GSK plc 584 shares @ £14.545 0.2% of flow GB00BN7SWP63⌘ RNS:5737340-23 ● SVP, Global Communications and CEO Office · Executives · 9 Jul 2025 · GSK plc 18 shares @ £14.2072 0.0% of flow GB00BN7SWP63⌘ RNS:5737340-3 Ideal exit: 5 Apr 2026 (T+270) ● SVP, Global Communications & CEO Office · Executives · 19 Jun 2025 · GSK plc 1,400 shares 0
GB00BN7SWP63⌘ RNS:5709676-0 ● SVP, Global Communications & CEO Office · Executives · 19 Jun 2025 · GSK plc 1,395 shares @ £14.3524 0.4% of flow GB00BN7SWP63⌘ RNS:5709676-1 ● SVP, Global Communications & CEO Office · Executives · 19 Jun 2025 · GSK plc 1,387 shares @ £14.3378 0.4% of flow GB00BN7SWP63⌘ RNS:5709676-2 Ideal exit: 16 Mar 2026 (T+270) ● SVP, Global Communications & CEO Office · Executives · 12 Jun 2025 · GSK plc 29,763 shares @ £15.4447 8.8% of flow GB00BN7SWP63⌘ RNS:5695943 ● SVP, Global Communications and CEO Office · Executives · 10 Jun 2025 · GSK plc 16 shares @ £14.9462 0.0% of flow GB00BN7SWP63⌘ RNS:202506120600PR_NEWS_UKDISCLO_0053-3 Ideal exit: 7 Mar 2026 (T+270) ● SVP, Global Communications and CEO Office · Executives · 12 May 2025 · GSK plc 18 shares @ £13.5078 0.0% of flow GB00BN7SWP63⌘ RNS:5652536-3 Ideal exit: 6 Feb 2026 (T+270) ● SVP, Global Communications and CEO Office · Executives · 16 Apr 2025 · GSK plc 658 shares @ £12.75 0.2% of flow GB00BN7SWP63⌘ RNS:5622701-4 ● SVP, Global Communications and CEO Office · Executives · 10 Apr 2025 · GSK plc 0
GB00BN7SWP63⌘ RNS:5617047-11 Ideal exit: 5 Jan 2026 (T+270) ● SVP, Global Communications and CEO Office · Executives · 9 Apr 2025 · GSK plc 20 shares @ £12.6155 0.0% of flow GB00BN7SWP63⌘ RNS:5615070-3 Ideal exit: 4 Jan 2026 (T+270) ● SVP, Global Communications and CEO Office · Executives · 10 Apr 2025 · GSK plc 22 shares @ £13.1268 0.0% of flow GB00BN7SWP63⌘ RNS:5615070-12 Ideal exit: 5 Jan 2026 (T+270) 25 of 84 declarations
Load more (59 remaining) About Sally Jackson Public sources indicate that Sally Jackson is SVP, Global Communications and CEO Office at GSK plc. GSK also names her in recent annual-report materials, but the retrieved sources do not provide a detailed public biography for this individual. Sources: https://www.gsk.com/media/0t2lqb2w/2025-annual-report-on-form-20-f.pdf